Reference | Author | Publication year | Geographic background | Study design | Gail model version | 5/10-year risk | Sample size | Mean age (years) | Study population | Risk for breast cancera | Time period | Follow-up period | C-statistic/AUC (95% CI) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[11] | Rockhill | 2001 | America | Cohort | 2 | 5 | 82,109 | 45–71 | Nurses’ Health Study (NHS) | General population | 1992–1997 | 5.0 | 0.58 (0.56–0.60) |
[30] | Amir | 2003 | United Kingdom | Cohort | 2 | 10 | 3150 | 21–73 | Women attending the Family History Screening Programme in University Hospital of South Manchester | Not defined | 1987–2001 | 5.0 | 0.74 (0.67–0.80) |
[21] | Tice | 2005 | America | Cohort | 2 | 5 | 81,777 | 55.9 | Community-based registry San Francisco Mammography Registry (SFMR) | General population | 1993–2002 | 5.1 (0.1–15) | 0.67 (0.65–0.68) |
[29] | Decarli | 2006 | Italy | Cohort | 2 | 5 | 10,031 | 35–64 | Florence—European Prospective Investigation Into Cancer and Nutrition cohort (EPIC) | General population | 1993–2002 | 9.0 | 0.59 (0.55–0.63) |
[36] | Crispo | 2008 | Italy | Case–control | 1 | 5 | 1765 | 53.7 | National Cancer Institute of Naples (southern Italy) | NA | 1997–2000 | NA | 0.55 (0.53–0.58) |
[15] | Tice | 2008 | America | Cohort | 2 | 5 | 251,789 | 40–74 | National Cancer Institute-funded Breast Cancer Surveillance Consortium (BCSC) | General population | since 1994 | 5.3 | 0.61 (0.60–0.62) |
[42] | Pan | 2009 | China | Cross-sectional | 1 | 5 | 2133 | > 35 | Breast cancer risk assessment, evaluation and health education program, in Beijing and Guangzhou community | NA | 2006–2007 | NA | 0.64 (0.61–0.67) |
[43] | Liu | 2010 | China | Cross-sectional | 2 | 5 | 246 | 49.82 | High-risk breast cancer screening model and chemical intervention study at the community level | NA | 2007–2009 | NA | 0.56 (0.49–0.64) |
[44] | Wang | 2010 | China | Case–control | 1 | 5 | 228 | 32–75 | Shenzhou Hospital of Shenyang Medical College-based breast cancer cases and control | NA | 1998–2007 | NA | 0.93 (0.89–0.97) |
[17] | Tarabishy | 2011 | America | Cohort | 2 | 5 | 4726 | 18–85 | Mayo Benign Breast Disease (BBD) | High risk | 1982–1991 | 16.2 | 0.64 (0.62–0.66) |
[22] | Vacek | 2011 | America | Cohort | 1 | 5 | 19,779 | > 70 | Vermont Breast Cancer Surveillance System (VBCSS) | High risk | 2001–2009 | 7.1 | 0.54 (0.52–0.56) |
[27] | Banegas | 2012 | America | Cohort | 2 | 5 | 128,976 | 63.51 | Women’s Health Initiative (WHI) | General population | 1993–2005 | 5.0 | 0.58 (0.57–0.59) |
[23] | Quante | 2012 | America | Cohort | 2 | 10 | 1857 | 44 | Women with high risk for breast or ovarian cancer in New York site of the Breast Cancer Family Registry (BCFR) | High risk | 1995–2011 | 8.1 | 0.63 (0.58–0.69) |
[32] | Pastor-Barriuso | 2013 | Spain | Cohort | 2 | 5 | 54,649 | 45–68 | Population-based Navarre Breast Cancer Screening Program (NBCSP) | General population | 1996–2005 | 7.7 | 0.54 (0.52–0.57) |
[51] | Dite | 2013 | Australia | Case–control | 2 | 5 | 1425 | 45.4 | Cases and controls from the Australian Breast Cancer Family Registry (ABCFR) | NA | 1992–1998 | NA | 0.58 (0.55–0.61) |
[40] | Anothaisintawee | 2013 | Thailand | Cross-sectional | NA | NA | 15,718 | NA | Ramathibodi Hospital and two tertiary hospitals | NA | 2011–2013 | NA | 0.41 (0.36–0.46) |
[24] | Ronser | 2013 | America | Cohort | 2 | 5 | 11,419 | 54.0 ± 3.3 | Postmenopausal women in California Teachers Study (CTS) | High risk | 1995–2009 | 5.0 | 0.55 (0.53–0.56) |
[41] | Min-1 | 2014 | Korea | Cohort | 2 | 5 | 40,229 | > 10 | Breast cancer screening patients routinely screened in Women’s Healthcare Center of Cheil General Hospital | Not defined | 1999–2004 | 5 | 0.55 (0.50–0.59) |
[41] | Min-2 | 2014 | Korea | Cohort | 3 | 5 | 40,229 | > 10 | Breast cancer screening patients routinely screened in Women’s Healthcare Center of Cheil General Hospital | Not defined | 1999–2004 | 5 | 0.54 (0.50–0.59) |
[18] | Powell | 2014 | America | Cohort | 2 | 5 | 12,843 | NA | Marin Women’s Study with high rate of breast cancer, null parity and delayed childbirth | High risk | 2003–2007 | 7.7 | 0.62 (0.59–0.66) |
[45] | Duan | 2014 | China | Case–control | 2 | 5 | 400 | 35–74 | Breast cancer cases and controls in the First Affiliate Hospital of KunMing Medical University | NA | 2007–2011 | NA | 0.54 (0.49–0.60) |
[19] | McCarthy | 2015 | America | Cohort | 2 | 5 | 464 | 48.7 ± 13 | Women referred for biopsy with abnormal (Breast Imaging Reporting And Data System, BI-RADS 4) mammograms at the Hospital of the University of Pennsylvania | High risk | 2003–2012 | 5.0 | 0.71 (0.65–0.78) |
[34] | Dartois-1 | 2015 | France | Cohort | 2 | 5 | 5843 | 42–72 | Premenopausal Women in French E3N (E´ tude E´ pide´miologique aupre`s des femmes de laMutuelle Ge´ne´rale de l’E´ ducation Nationale (MGEN)) prospective cohort to investigate the cancer risk factors | General population | 1993–1998 | 5.0 | 0.61 (0.55–0.68) |
[34] | Dartois-2 | 2015 | France | Cohort | 2 | 5 | 7331 | 42–72 | Postmenopausal Women in French E3N (E´ tude E´ pide´miologique aupre`s des femmes de laMutuelle Ge´ne´rale de l’E´ ducation Nationale (MGEN)) prospective cohort to investigate the cancer risk factors | High risk | 1993–1998 | 14.0 | 0.55 (0.50–0.60) |
[39] | Hu | 2015 | China | Cohort | 2 | 5 | 42,908 | 35–69 | Women participated in the breast cancer screening in Zhejiang eastern coastal areas of China | General population | 2008–2014 | 5.0 | 0.59 (0.47–0.70) |
[35] | Brentnall | 2015 | United Kingdom | Cohort | 2 | 10 | 50,628 | 47–73 | 15 screening areas in Greater Manchester, UK | General population | 2009–2014 | 3.2 | 0.54 (0.52–0.56) |
[20] | Schonberg-1 | 2015 | America | Cohort | 2 | 5 | 71,293 | 70.0 ± 7.0 | Nurses’ Health Study (NHS) | High risk | 2004–2009 | 5.0 | 0.57 (0.55–0.58) |
[20] | Schonberg-2 | 2015 | America | Cohort | 2 | 5 | 79,611 | 71.0 ± 6.8 | Women’s Health Initiative (WHI), extensive study | High risk | 2005–2010 | 5.0 | 0.58 (0.56–0.59) |
[46] | Rong | 2016 | China | Case–control | 1 | 5 | 816 | 48.9 | Breast cancer cases and controls in the Shenzhen Maternal and Child Health Care hospital | NA | 2011–2013 | NA | 0.69 (0.68–0.71) |